Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0000950170-24-085089

EVP, Chief Financial Officer acquired 3,875 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Duarte Ira EVP, Chief Financial Officer 2024-07-19 Option exercise +3,875 104,127 D
Derivatives
Duarte Ira EVP, Chief Financial Officer 2024-07-19 Option exercise · Restricted Stock Units −3,875 54,240 D
Loading xslF345X05/ownership.xml…